Show simple item record

dc.creatorRadak, Đorđe J.
dc.creatorKatsiki, Niki
dc.creatorResanović, Ivana
dc.creatorJovanović, Aleksandra
dc.creatorSudar, Emina
dc.creatorZafirović, Sonja
dc.creatorMousa, Shaker A.
dc.creatorIsenović, Esma R.
dc.date.accessioned2018-03-01T17:32:55Z
dc.date.available2018-03-01T17:32:55Z
dc.date.issued2017
dc.identifier.issn1570-1611 (print)
dc.identifier.issn1875-6212 (electronic)
dc.identifier.urihttp://vinar.vin.bg.ac.rs/handle/123456789/1521
dc.description.abstractApoptosis may contribute to a significant proportion of neuron death following acute brain ischemia (ABI), but the underlying mechanisms are still not fully understood. Brain ischemia may lead to stroke, which is one of the main causes of long-term morbidity and mortality in both developed and developing countries. Therefore, stroke prevention and treatment is clinically important. There are two important separate areas of the brain during ABI: the ischemic core and the ischemic penumbra. The ischemic core of the brain experiences a sudden reduction of blood flow, just minutes after ischemic attack with irreversible injury and subsequent cell death. On the other hand, apoptosis within the ischemic penumbra may occur after several hours or days, while necrosis starts in the first hours after the onset of ABI in the ischemic core. ABI is characterized by key molecular events that initiate apoptosis in many cells, such as overproduction of free radicals, Ca2+ overload and excitotoxicity. These changes in cellular homeostasis may trigger either necrosis or apoptosis, which often depends on cell type, cell age, and location in the brain. Apoptosis results in DNA fragmentation, degradation of cytoskeletal and nuclear proteins, cross-linking of proteins, formation of apoptotic bodies, expression of ligands for phagocytic cell receptors and finally uptake by phagocytic cells. This review focuses on recent findings based on animal and human studies regarding the apoptotic mechanisms of neuronal death following ABI and the development of potential neuroprotective agents that reduce morbidity. The effects of statins on stroke prevention and treatment as well as on apoptotic mediators are also considered.en
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41002/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173033/RS//
dc.rightsrestrictedAccessen
dc.sourceCurrent Vascular Pharmacologyen
dc.subjectApoptosisen
dc.subjectacute brain ischemiaen
dc.subjectstrokeen
dc.subjectcaspaseen
dc.subjectdeath receptoren
dc.subjectstatinsen
dc.titleApoptosis and Acute Brain Ischemia in Ischemic Strokeen
dc.typereviewen
dcterms.abstractРадак, Дјордје; Ресановић Ивана; Катсики, Ники; Јовановић Aлександра; Моуса, Схакер A.; Судар Емина; Зафировић Соња; Исеновић Есма;
dc.citation.volume15
dc.citation.issue2
dc.citation.spage115
dc.citation.epage122
dc.identifier.wos000399590800004
dc.identifier.doi10.2174/1570161115666161104095522
dc.identifier.pmid27823556
dc.identifier.scopus2-s2.0-85011048703


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record